Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 65,495 | 43,633 | 26,413 | 13,863 | 250,418 |
| Depreciation Amortization | 18,821 | 14,397 | 10,377 | 4,819 | 121,322 |
| Income taxes - deferred | 7,097 | 4,464 | 3,125 | -1,106 | 42,942 |
| Accounts receivable | -71,882 | -24,112 | -39,141 | -12,288 | 103,523 |
| Other Working Capital | -86,457 | -44,953 | -56,347 | -12,955 | 82,197 |
| Other Operating Activity | 73,053 | 17,025 | 40,330 | 8,678 | -350,641 |
| Operating Cash Flow | $6,127 | $10,454 | $-15,243 | $1,011 | $249,761 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,480 | 35,675 | 59,724 | 47,625 | -197,368 |
| PPE Investments | -30,524 | -18,433 | -14,569 | -8,723 | -16,267 |
| Investing Cash Flow | $-15,044 | $17,242 | $45,155 | $38,902 | $-213,635 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,774 | 12,632 | 10,833 | 6,669 | 17,728 |
| Other Financing Activity | 6,535 | 6,086 | 5,641 | 2,353 | 6,172 |
| Financing Cash Flow | $21,309 | $18,718 | $16,474 | $9,022 | $23,900 |
| Exchange Rate Effect | 231 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 91,796 | 91,796 | 91,796 | 91,796 | 31,770 |
| End Cash Position | 104,419 | 138,210 | 138,182 | 140,731 | 91,796 |
| Net Cash Flow | $12,623 | $46,414 | $46,386 | $48,935 | $60,026 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,127 | 10,454 | -15,243 | 1,011 | 249,761 |
| Capital Expenditure | -30,524 | -18,433 | -14,569 | -8,723 | -16,267 |
| Free Cash Flow | -24,397 | -7,979 | -29,812 | -7,712 | 233,494 |